Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Authors : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, Tkint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ Year : 2022 Journal : Prostate Cancer Prostatic Dis
Management of early breast cancer in patients bearing germline BRCA mutations.
Authors : Tkint de Roodenbeke D, Pondé N, Buisseret L, Piccart-Gebhart M Year : 2020 Journal : Semin Oncol
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Authors : Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, Tkint de Roodenbeke D, Willard-Gallo K Year : 2019 Journal : Cancer Lett
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Authors : Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HA Jr, Desir J, Delbaere A, Tkint de Roodenbeke D, de Azambuja E, Ignatiadis M, Demeestere I Year : 2018 Journal : Ann Oncol
Soins Intensifs Oncologiques : revue des années 2013 et 2014
Authors : Sculier JP, Bucalau AM, Closset J, Compagnie M, Gorham J, Sideris S, Tkint de Roodenbeke D, Wang X, Berghmans T, Meert AP Year : 2016 Journal : Rev Med Brux